# Icarus Medical Innovations

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/icarus-medical-innovations

- Industry: Healthcare
- Headquarters: Charlottesville, US
- Website: www.icarusmedical.com/
- Total disclosed funding: $7.2M
- Latest round: Series A (Jun 18, 2026)
- Investors on record: 6

## About

Icarus Medical Innovations, based in the US, specializes in the development and production of advanced orthopedic brace technologies aimed at enhancing patient mobility and alleviating pain.Founded in 2019 in Charlottesville, US, Icarus Medical focuses on creating innovative orthopedic braces. The company has undergone a strategic pivot towards developing advanced technologies to cater to diverse patient needs and has successfully established a presence in both domestic and select international markets. Icarus Medical received funding of USD 7.2 mn from investors including Blu Venture Investors and Highpoint Ventures during its latest funding round on June 22, 2026, bringing its total amount raised to USD 7.2 mn.Icarus Medical specializes in advanced knee, leg, and ankle brace technologies designed to enhance mobility and reduce pain for various patient needs. Their core product offerings include the Ascender, a lightweight and form-fitting tricompartment unloader brace, and the Adonis, which provides joint distraction for managing medial and lateral osteoarthritis while protecting the meniscus. Additionally, their innovative Hermes AFO is a dynamically adjustable ankle-foot orthosis, and the Hercules KAFO is an ultralight brace that assists in knee extension. The Kronos post-operative knee brace promotes comfortable recovery, while the Zeus brace supports patients with severe lower-limb weakness. Icarus Medical targets a diverse customer base that includes individuals recovering from injuries, athletes, veterans, and patients suffering from chronic conditions across the United States and various international markets such as Canada and select European countries.Icarus Medical generates revenue primarily through direct-to-consumer transactions and partnerships with healthcare providers and clinics. The company sells its braces on a per-unit basis, allowing customers to purchase individual products tailored to their specific needs. Flagship products like the Ascender and Adonis are positioned as premium solutions for patients experiencing significant knee-related issues. The pricing structure reflects the custom-fit nature of these products, uniquely tailored to each user through a proprietary scan-to-fabrication process, with healthcare professionals recommending Icarus bracing solutions as part of comprehensive treatment plans, further solidifying the company's presence in the orthopedic rehabilitation market.Icarus Medical Innovations plans to leverage the USD 7.2 mn raised in June 2026 to enhance its product offerings and expand into new markets. The company is currently developing additional orthopedic devices aimed at improving patient outcomes and expects to launch these products within the next two years. Furthermore, Icarus Medical is exploring opportunities for market expansion into regions such as Europe and Asia, targeting a broader international customer base by 2028.

## Funding rounds

- Series A, Jun 18, 2026, $7.2M — Blu Venture Investors, OSF Ventures, CU Healthcare Innovation Fund, Riptide Ventures, Highpoint Ventures, Neovate Capital Partners

## Investors

- Blu Venture Investors (https://capitalatlas.ai/funds/blu-venture-investors) — Series A
- OSF Ventures (https://capitalatlas.ai/funds/osf-ventures) — Series A
- CU Healthcare Innovation Fund (https://capitalatlas.ai/funds/cu-healthcare-innovation-fund) — Series A
- Riptide Ventures (https://capitalatlas.ai/funds/riptide-ventures) — Series A
- Highpoint Ventures (https://capitalatlas.ai/funds/highpoint-ventures) — Series A
- Neovate Capital Partners (https://capitalatlas.ai/funds/neovate-capital-partners) — Series A